Evidence map›Paper›PMID 23205001›Full record

ArticlePoiesis & praxis : international journal of ethics of science and technology assessment2012

Ethical aspects of vulnerability in research.

Elisabeth Weisser-Lohmann

Abstract read
In one paragraph

Article in Poiesis & praxis : international journal of ethics of science and technology assessment, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. COVID-19 and the moral failure to protect the most vulnerable.Journal of healthcare, science and the humanities
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Elisabeth Weisser-LohmannHagen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In connection with research on humans, the term "vulnerability" is only appropriate to identify the special need for protection of certain sections of the population and individuals, if this term refers to the additional risk of certain groups of subjects. Authors who focus on the additional risk suffering of a subject group when defining vulnerability succeed in considering the specific worthiness of protection in a context-sensitive way. The attempt to define the risk-benefit assessment for vulnerable subject groups on a binding basis faces considerable difficulties. This assessment depends both on the research situation and on the test subject. The normative aspect of this decision could be solved by referring to Rawl's decision model of an original position. In cases where there is no benefit for the subject, arguments in the discussion of the risks and benefits that are based on a "group or overall benefit" and an "objective interest," cannot be fully sustained.

Identifiers

PMID23205001
PMCPMC3510404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.